0000899243-19-029809.txt : 20191220 0000899243-19-029809.hdr.sgml : 20191220 20191220182607 ACCESSION NUMBER: 0000899243-19-029809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191218 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eriksson Patrik CENTRAL INDEX KEY: 0001788001 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 191303074 MAIL ADDRESS: STREET 1: 250 S. KRAEMER BLVD STREET 2: BLDG E CITY: BREA STATE: CA ZIP: 92821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-516-7774 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-18 0 0001757073 Envista Holdings Corp NVST 0001788001 Eriksson Patrik C/O ENVISTA HOLDINGS CORPORATION 200 S. KRAEMER BLVD, BLDG. E BREA CA 92821 0 1 0 0 SENIOR VICE PRESIDENT Common Stock 2019-12-18 4 A 0 55016 0.00 A 67971 D Employee Stock Option (Right to Buy) 12.62 2019-12-18 4 A 0 4914 0.00 A 2025-02-24 Common Stock 4914 4914 D Employee Stock Option (Right to Buy) 12.65 2019-12-18 4 A 0 14654 0.00 A 2026-02-24 Common Stock 14654 14654 D Employee Stock Option (Right to Buy) 16.51 2019-12-18 4 A 0 20033 0.00 A 2027-02-24 Common Stock 20033 20033 D Employee Stock Option (Right to Buy) 19.04 2019-12-18 4 A 0 32240 0.00 A 2028-02-24 Common Stock 32240 32240 D Employee Stock Option (Right to Buy) 19.04 2019-12-18 4 A 0 40327 0.00 A 2028-02-24 Common Stock 40327 40327 D Employee Stock Option (Right to Buy) 21.76 2019-12-18 4 A 0 38344 0.00 A 2029-02-24 Common Stock 38344 38344 D Employee Stock Option (Right to Buy) 21.76 2019-12-18 4 A 0 38344 0.00 A 2029-02-24 Common Stock 38344 38344 D These are restricted stock units ("RSUs") that were originally granted by Danaher Corporation ("Danaher") and, in connection with Issuer's separation from Danaher on December 18, 2019 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of September 19, 2019, by and between Danaher and Issuer (the "Employee Matters Agreement"), were adjusted into RSUs relating to shares of Issuer common stock. Includes 7,955 RSUs that were previously reported in Table II. These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. This Option will vest as to 4,914 shares of Issuer common stock on February 24, 2020, subject to continued service through such date. The remainder of the Option is fully vested. This Option will vest as to 7,327 shares of Issuer common stock on each of February 24, 2020 and February 24, 2021, subject to continued service through each such date. The remainder of the Option is fully vested. This Option will vest as to 6,677 shares of Issuer common stock on each of February 24, 2020 and February 24, 2021 and as to 6,679 shares of Issuer common stock on February 24, 2022, subject to continued service through each such date. The remainder of the Option is fully vested. This Option will vest as to 6,448 shares of Issuer common stock on each of February 24, 2020, February 24, 2021, February 24, 2022 and February 24, 2023, subject to continued service through each such date. The remainder of the Option is fully vested. This Option will vest as to 8,065 shares of Issuer common stock on each of February 24, 2020, February 24, 2021 and February 24, 2022 and as to 8,067 shares of Issuer common stock on February 24, 2023, subject to continued service through each such date. The remainder of the Option is fully vested. This Option will vest as to 7,668 shares of Issuer common stock on each of February 24, 2020, February 24, 2021, February 24, 2022 and February 24, 2023 and as to 7,672 shares of Issuer common stock on February 24, 2024, subject to continued service through each such date. This Option will vest as to 7,668 shares of Issuer common stock on each of February 24, 2020, February 24, 2021, February 24, 2022 and February 24, 2023 and as to 7,672 shares of Issuer common stock on February 24, 2024, subject to continued service through each such date. /s/ Heather Turner, Attorney-in-Fact 2019-12-20 EX-24 2 attachment1.htm EX-24 DOCUMENT

                          SUBSTITUTE POWER OF ATTORNEY

                               December 17, 2019

    Under the terms of powers of attorney (each, a "Power of Attorney")
previously filed with the U.S. Securities and Exchange Commission, the
undersigned was appointed an attorney-in-fact for the following individuals to,
among other things, execute, deliver and file for and on behalf of the following
individuals in their respective capacities as officers or directors of Envista
Holdings Corporation (the "Company") any Forms 3, 4 or 5, in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder:

          Scott Huennekens
          Amir Aghdaei
          Wendy Carruthers
          William K. Daniel II
          Daniel Raskas
          Christine Tsingos
          Curt Bludworth
          Howard Yu
          Mischa Reis
          Hans Geiselhoeringer
          Patrick Eriksson
          Jeffrey Kappler
          Kari-Lyn Moore

    In accordance with the authority granted under each Power of Attorney,
including the power of substitution, the undersigned hereby appoints Heather
Turner as substitute attorney-in-fact, on behalf of each individual named above,
with the power to exercise and execute all of the powers granted to or conferred
upon the undersigned in the original Power of Attorney.

    This Substitute Power of Attorney shall become effective as of the date
first written above and shall remain in full force and effect with respect to
the named individual until the named individual is no longer required to file
Forms 3, 4 and 5 with respect to the named individual's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned or by the named individual in a signed writing delivered to the
substitute attorney-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of
Attorney to be executed on the date first written above.



/s/ Mark Nance
--------------------------------
Mark Nance
Attorney-in-Fact